Month: January 2012
-
January is Glaucoma Awareness Month; disease is second leading cause of blindness
One million Americans will be diagnosed with glaucoma in the next 10 years, prompting Kentucky optometrists to raise awareness of the disease this month. “People who do not visit their...
-
“Stop Meth, Not Meds,” ad sponsored by drug industry advises
With some legislators saying a law is needed to make the decongestant pseudoephedrine available only by prescription, the Kentucky Healthcare Products Association has launched an advertising campaign to fight the...
-
Foundation funded by drug companies calls pill abuse overblown
Almost 15,000 Americans die a year from prescription pain medication, a statistic that has the Centers for Disease Control and Prevention calling the problem “an epidemic.” But while the issue...
-
Pain clinics in Texas skirting law by calling themselves ‘wellness’ or ‘rehab’ facilities
Calling themselves rehabilitation or wellness clinics is the latest way operators of pill mills are skirting the law in Texas, which requires pain management clinics to register and be inspected...
-
Doctor report cards will be as big a failure as No Child Left Behind, physician contends in op-ed piece
Tying physicians’ reimbursements to how well they score on a Medicare report card is akin to the federal government having schools submit to No Child Left Behind, asserts Dr. Barry...
-
Smoking hookahs can cause carbon monoxide poisoning
Though they’re often viewed as just cool and unusual, hookahs, exotic-looking water pipes that can be smoked at several restaurants and bars in Lexington and Louisville, can cause carbon-monoxide poisoning....
-
Evidence grows of links between oral health and overall health
“The eyes may be the window to the soul, but the mouth provides an even better view of the body as a whole,” The Wall Street Journal‘s Melinda Beck writes...
-
Pure hydrocodone pain pill in testing; critics worry about abuse
A new pain pill, one more powerful than OxyContin and 10 times stronger than Vicodin, is being tested on patients by four drug companies and could be out as early...